关键信息
-
基因名
RC0497
- 应用
-
别名
RC0497; Putative N-acetylmuramoyl-L-alanine amidase RC0497; EC 3.5.1.28
-
种属
Rickettsia conorii
-
表达系统
E. coli
-
标签
N- His-SUMO
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q92IC3
-
表达区间
1-267aa
-
分子量
45.6 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
RC0497 is a recombinant protein that has garnered attention in the field of biomedicine due to its potential applications in therapeutic interventions and diagnostics. This protein, derived from a specific gene sequence, has been engineered to exhibit unique properties that facilitate its interaction with various biological systems. Research on RC0497 explores its role in modulating immune responses, making it a candidate for vaccine development and cancer immunotherapy. The background of RC0497 research encompasses the pressing need for novel therapeutic agents that can effectively target diseases with unmet medical needs. The increased prevalence of various conditions, such as cancers and chronic infections, underscores the importance of understanding how engineered proteins like RC0497 can influence cellular mechanisms. By elucidating its structure-function relationships, scientists aim to optimize its efficacy and safety profiles. Additionally, ongoing studies focus on the protein's biochemical characteristics, metabolic pathways, and potential side effects, contributing to a comprehensive understanding of its therapeutic potential. Overall, RC0497 represents a promising avenue in protein engineering, reflecting broader trends in personalized medicine and innovative biotechnological approaches to health challenges.
